Selected research
Industry Research
Anti-Mullerian Hormone (AMH) Test Industry Research Report 2026
Market perspective
The global Anti-Mullerian Hormone (AMH) Test market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Anti-Mullerian Hormone (AMH) Test market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Anti-Mullerian Hormone (AMH) Test market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Anti-Mullerian Hormone (AMH) Test market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Anti-Mullerian Hormone (AMH) Test include Roche, Beckman Coulter, BioMérieux, Monash IVF, Bumrungrad International Hospital, CTK Biotech, Biotime, Boditech Med and CREATE Fertility, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Anti-Mullerian Hormone (AMH) Test market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Anti-Mullerian Hormone (AMH) Test.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Anti-Mullerian Hormone (AMH) Test Market by Company
Roche
Beckman Coulter
BioMérieux
Monash IVF
Bumrungrad International Hospital
CTK Biotech
Biotime
Boditech Med
CREATE Fertility
Repromed Fertility Specialists
Quest Health
Clinpath Pathology
Shenzhen YHLO Biotech
Guangzhou Kangrun Biotechnology
Guangzhou Wondfo Biotech
Beijing Savant Biotechnology
Anti-Mullerian Hormone (AMH) Test Segment by Type
Chemiluminescence Immunoassay
ELISA
Magnetic Particle Chemiluminescence
Flow Cytometry Fluorescence Luminescence
Other
Anti-Mullerian Hormone (AMH) Test Segment by Application
Assisted Reproduction
Polycystic Ovary Syndrome
Ovarian Cancer
Other
Anti-Mullerian Hormone (AMH) Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Mullerian Hormone (AMH) Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Mullerian Hormone (AMH) Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Mullerian Hormone (AMH) Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Anti-Mullerian Hormone (AMH) Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Chemiluminescence Immunoassay
- ELISA
- Magnetic Particle Chemiluminescence
- Flow Cytometry Fluorescence Luminescence
- Other
Applications
- Assisted Reproduction
- Polycystic Ovary Syndrome
- Ovarian Cancer
- Other
Companies covered
- Roche
- Beckman Coulter
- BioMérieux
- Monash IVF
- Bumrungrad International Hospital
- CTK Biotech
- Biotime
- Boditech Med
- CREATE Fertility
- Repromed Fertility Specialists
- Quest Health
- Clinpath Pathology
- Shenzhen YHLO Biotech
- Guangzhou Kangrun Biotechnology
- Guangzhou Wondfo Biotech
- Beijing Savant Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Anti-Mullerian Hormone (AMH) Test by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Chemiluminescence Immunoassay
- 2.2.3 ELISA
- 2.2.4 Magnetic Particle Chemiluminescence
- 2.2.5 Flow Cytometry Fluorescence Luminescence
- 2.2.6 Other
- 2.3 Anti-Mullerian Hormone (AMH) Test by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Assisted Reproduction
- 2.3.3 Polycystic Ovary Syndrome
- 2.3.4 Ovarian Cancer
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Anti-Mullerian Hormone (AMH) Test Breakdown Data by Type
- 3.1 Global Anti-Mullerian Hormone (AMH) Test Historic Market Size by Type (2021-2026)
- 3.2 Global Anti-Mullerian Hormone (AMH) Test Forecasted Market Size by Type (2027-2032)
4 Anti-Mullerian Hormone (AMH) Test Breakdown Data by Application
- 4.1 Global Anti-Mullerian Hormone (AMH) Test Historic Market Size by Application (2021-2026)
- 4.2 Global Anti-Mullerian Hormone (AMH) Test Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Anti-Mullerian Hormone (AMH) Test Market Perspective (2021-2032)
- 5.2 Global Anti-Mullerian Hormone (AMH) Test Growth Trends by Region
- 5.2.1 Global Anti-Mullerian Hormone (AMH) Test Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Anti-Mullerian Hormone (AMH) Test Historic Market Size by Region (2021-2026)
- 5.2.3 Anti-Mullerian Hormone (AMH) Test Forecasted Market Size by Region (2027-2032)
- 5.3 Anti-Mullerian Hormone (AMH) Test Market Dynamics
- 5.3.1 Anti-Mullerian Hormone (AMH) Test Industry Trends
- 5.3.2 Anti-Mullerian Hormone (AMH) Test Market Drivers
- 5.3.3 Anti-Mullerian Hormone (AMH) Test Market Challenges
- 5.3.4 Anti-Mullerian Hormone (AMH) Test Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Anti-Mullerian Hormone (AMH) Test Players by Revenue
- 6.1.1 Global Top Anti-Mullerian Hormone (AMH) Test Players by Revenue (2021-2026)
- 6.1.2 Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Players (2021-2026)
- 6.2 Global Anti-Mullerian Hormone (AMH) Test Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Anti-Mullerian Hormone (AMH) Test Head Office and Area Served
- 6.4 Global Anti-Mullerian Hormone (AMH) Test Players, Product Type & Application
- 6.5 Global Anti-Mullerian Hormone (AMH) Test Manufacturers Established Date
- 6.6 Global Anti-Mullerian Hormone (AMH) Test Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032)
- 7.2 North America Anti-Mullerian Hormone (AMH) Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026)
- 7.4 North America Anti-Mullerian Hormone (AMH) Test Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032)
- 8.2 Europe Anti-Mullerian Hormone (AMH) Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026)
- 8.4 Europe Anti-Mullerian Hormone (AMH) Test Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032)
- 9.2 Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Anti-Mullerian Hormone (AMH) Test Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032)
- 10.2 South America Anti-Mullerian Hormone (AMH) Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026)
- 10.4 South America Anti-Mullerian Hormone (AMH) Test Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size (2021-2032)
- 11.2 Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Anti-Mullerian Hormone (AMH) Test Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Roche
- 12.1.1 Roche Company Information
- 12.1.2 Roche Business Overview
- 12.1.3 Roche Revenue in Anti-Mullerian Hormone (AMH) Test Business (2021-2026)
- 12.1.4 Roche Anti-Mullerian Hormone (AMH) Test Product Portfolio
- 12.1.5 Roche Recent Developments
- 12.2 Beckman Coulter
- 12.2.1 Beckman Coulter Company Information
- 12.2.2 Beckman Coulter Business Overview
- 12.2.3 Beckman Coulter Revenue in Anti-Mullerian Hormone (AMH) Test Business (2021-2026)
- 12.2.4 Beckman Coulter Anti-Mullerian Hormone (AMH) Test Product Portfolio
- 12.2.5 Beckman Coulter Recent Developments
- 12.3 BioMérieux
- 12.3.1 BioMérieux Company Information
- 12.3.2 BioMérieux Business Overview
- 12.3.3 BioMérieux Revenue in Anti-Mullerian Hormone (AMH) Test Business (2021-2026)
- 12.3.4 BioMérieux Anti-Mullerian Hormone (AMH) Test Product Portfolio
- 12.3.5 BioMérieux Recent Developments
- 12.4 Monash IVF
- 12.4.1 Monash IVF Company Information
- 12.4.2 Monash IVF Business Overview
- 12.4.3 Monash IVF Revenue in Anti-Mullerian Hormone (AMH) Test Business (2021-2026)
- 12.4.4 Monash IVF Anti-Mullerian Hormone (AMH) Test Product Portfolio
- 12.4.5 Monash IVF Recent Developments
- 12.5 Bumrungrad International Hospital
- 12.5.1 Bumrungrad International Hospital Company Information
- 12.5.2 Bumrungrad International Hospital Business Overview
- 12.5.3 Bumrungrad International Hospital Revenue in Anti-Mullerian Hormone (AMH) Test Business (2021-2026)
- 12.5.4 Bumrungrad International Hospital Anti-Mullerian Hormone (AMH) Test Product Portfolio
- 12.5.5 Bumrungrad International Hospital Recent Developments
- 12.6 CTK Biotech
- 12.6.1 CTK Biotech Company Information
- 12.6.2 CTK Biotech Business Overview
- 12.6.3 CTK Biotech Revenue in Anti-Mullerian Hormone (AMH) Test Business (2021-2026)
- 12.6.4 CTK Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio
- 12.6.5 CTK Biotech Recent Developments
- 12.7 Biotime
- 12.7.1 Biotime Company Information
- 12.7.2 Biotime Business Overview
- 12.7.3 Biotime Revenue in Anti-Mullerian Hormone (AMH) Test Business (2021-2026)
- 12.7.4 Biotime Anti-Mullerian Hormone (AMH) Test Product Portfolio
- 12.7.5 Biotime Recent Developments
- 12.8 Boditech Med
- 12.8.1 Boditech Med Company Information
- 12.8.2 Boditech Med Business Overview
- 12.8.3 Boditech Med Revenue in Anti-Mullerian Hormone (AMH) Test Business (2021-2026)
- 12.8.4 Boditech Med Anti-Mullerian Hormone (AMH) Test Product Portfolio
- 12.8.5 Boditech Med Recent Developments
- 12.9 CREATE Fertility
- 12.9.1 CREATE Fertility Company Information
- 12.9.2 CREATE Fertility Business Overview
- 12.9.3 CREATE Fertility Revenue in Anti-Mullerian Hormone (AMH) Test Business (2021-2026)
- 12.9.4 CREATE Fertility Anti-Mullerian Hormone (AMH) Test Product Portfolio
- 12.9.5 CREATE Fertility Recent Developments
- 12.10 Repromed Fertility Specialists
- 12.10.1 Repromed Fertility Specialists Company Information
- 12.10.2 Repromed Fertility Specialists Business Overview
- 12.10.3 Repromed Fertility Specialists Revenue in Anti-Mullerian Hormone (AMH) Test Business (2021-2026)
- 12.10.4 Repromed Fertility Specialists Anti-Mullerian Hormone (AMH) Test Product Portfolio
- 12.10.5 Repromed Fertility Specialists Recent Developments
- 12.11 Quest Health
- 12.11.1 Quest Health Company Information
- 12.11.2 Quest Health Business Overview
- 12.11.3 Quest Health Revenue in Anti-Mullerian Hormone (AMH) Test Business (2021-2026)
- 12.11.4 Quest Health Anti-Mullerian Hormone (AMH) Test Product Portfolio
- 12.11.5 Quest Health Recent Developments
- 12.12 Clinpath Pathology
- 12.12.1 Clinpath Pathology Company Information
- 12.12.2 Clinpath Pathology Business Overview
- 12.12.3 Clinpath Pathology Revenue in Anti-Mullerian Hormone (AMH) Test Business (2021-2026)
- 12.12.4 Clinpath Pathology Anti-Mullerian Hormone (AMH) Test Product Portfolio
- 12.12.5 Clinpath Pathology Recent Developments
- 12.13 Shenzhen YHLO Biotech
- 12.13.1 Shenzhen YHLO Biotech Company Information
- 12.13.2 Shenzhen YHLO Biotech Business Overview
- 12.13.3 Shenzhen YHLO Biotech Revenue in Anti-Mullerian Hormone (AMH) Test Business (2021-2026)
- 12.13.4 Shenzhen YHLO Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio
- 12.13.5 Shenzhen YHLO Biotech Recent Developments
- 12.14 Guangzhou Kangrun Biotechnology
- 12.14.1 Guangzhou Kangrun Biotechnology Company Information
- 12.14.2 Guangzhou Kangrun Biotechnology Business Overview
- 12.14.3 Guangzhou Kangrun Biotechnology Revenue in Anti-Mullerian Hormone (AMH) Test Business (2021-2026)
- 12.14.4 Guangzhou Kangrun Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio
- 12.14.5 Guangzhou Kangrun Biotechnology Recent Developments
- 12.15 Guangzhou Wondfo Biotech
- 12.15.1 Guangzhou Wondfo Biotech Company Information
- 12.15.2 Guangzhou Wondfo Biotech Business Overview
- 12.15.3 Guangzhou Wondfo Biotech Revenue in Anti-Mullerian Hormone (AMH) Test Business (2021-2026)
- 12.15.4 Guangzhou Wondfo Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio
- 12.15.5 Guangzhou Wondfo Biotech Recent Developments
- 12.16 Beijing Savant Biotechnology
- 12.16.1 Beijing Savant Biotechnology Company Information
- 12.16.2 Beijing Savant Biotechnology Business Overview
- 12.16.3 Beijing Savant Biotechnology Revenue in Anti-Mullerian Hormone (AMH) Test Business (2021-2026)
- 12.16.4 Beijing Savant Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio
- 12.16.5 Beijing Savant Biotechnology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst